UBS Group’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$480K Buy
+44,000
New +$550K ﹤0.01% 6113
2025
Q2
Sell
-203,500
Closed -$3.63M 10663
2025
Q1
$3.63M Sell
203,500
-26,200
-11% -$595K ﹤0.01% 4119
2024
Q4
$6.85M Buy
229,700
+29,700
+15% +$629K ﹤0.01% 3491
2024
Q3
$3.13M Sell
200,000
-67,627
-25% -$1.23M ﹤0.01% 3540
2024
Q2
$4.58M Buy
+267,627
New +$4.71M ﹤0.01% 2959
2024
Q1
Sell
-38,600
Closed -$576K 9811
2023
Q4
$576K Sell
38,600
-2,900
-7% -$38.8K ﹤0.01% 4993
2023
Q3
$670K Hold
41,500
﹤0.01% 4423
2023
Q2
$1.72M Sell
41,500
-25,700
-38% -$1.6M ﹤0.01% 3678
2023
Q1
$4.04M Buy
67,200
+26,900
+67% +$2.15M ﹤0.01% 2723
2022
Q4
$2.96M Buy
40,300
+32,900
+445% +$2.48M ﹤0.01% 2990
2022
Q3
$562K Hold
7,400
﹤0.01% 4226
2022
Q2
$514K Hold
7,400
﹤0.01% 4241
2022
Q1
$613K Hold
7,400
﹤0.01% 4548
2021
Q4
$556K Hold
7,400
﹤0.01% 4898
2021
Q3
$860K Sell
7,400
-17,600
-70% -$2.66M ﹤0.01% 4315
2021
Q2
$5.55M Buy
+25,000
New +$4.86M ﹤0.01% 2573
2019
Q4
Sell
-18,600
Closed -$1.39M 8312
2019
Q3
$1.39M Sell
18,600
-31,400
-63% -$2.51M ﹤0.01% 3662
2019
Q2
$3.16M Hold
50,000
﹤0.01% 2727
2019
Q1
$2.41M Buy
+50,000
New +$2.41M ﹤0.01% 2836
2018
Q4
Sell
-50,000
Closed -$2.62M 8214
2018
Q3
$2.62M Hold
50,000
﹤0.01% 2967
2018
Q2
$1.56M Buy
+50,000
New +$1.39M ﹤0.01% 3385
2017
Q4
Sell
-75,000
Closed -$1.49M 8013
2017
Q3
$1.49M Hold
75,000
﹤0.01% 3373
2017
Q2
$1.3M Hold
75,000
﹤0.01% 3386
2017
Q1
$608K Buy
+75,000
New +$542K ﹤0.01% 3903

Other funds holding NVCR